Search

The June 15 edition of “MSK Science Spotlight,” features Derek Tan, PhD discussing “A Drug Discovery Journey from Tuberculosis to Cancer.”

… Monday, June 15, 2020 The June 15 edition of “ MSK Science Spotlight , ” features Derek Tan , PhD discussing “A Drug Discovery Journey from Tuberculosis to Cancer.” Dr. Tan is Chair of Chemical Biology Program at the Sloan Kettering Institute and Director of Tri-Institutional PhD Program in Chemical

In a world where one in every two people will be diagnosed with cancer in their lifetime, the Publicis Foundation is launching the first cross-industry coalition to erase the stigma of cancer in the workplace, supported by leading cancer charities and organizations including Memorial Sloan Kettering Cancer Center (MSK), MacMillan Cancer Support and the Gustave Roussy Institute.

… Tuesday, January 17, 2023 In a world where one in every two people will be diagnosed with cancer in their lifetime  (1) , the Publicis Foundation is launching the first cross-industry coalition to erase the stigma of cancer in the workplace, supported by leading cancer charities and organizations including

An MSK study explains how the drug selinexor, which was recently approved to treat multiple myeloma and is being tested in many other tumor types, stops cancer.

… Monday, September 16, 2019 Summary MSK researchers explain how selinexor works. The drug was recently approved to treat multiple myeloma and is being tested in many other tumor types. Cancer is caused by gene mutations, but sometimes it’s hard to figure out which mutations actually drive tumor growth

More than 20 years ago, this SKI scientist laid the groundwork for a field that is now transforming medicine.

… Wednesday, April 1, 2020 By Matt Tontonoz Maria Jasin woke up groggy from jet lag in her Paris hotel room. It was May 21, 2019. She was in the city for a scientific conference and later that morning would be heading over to the venue. But first she checked her email. There, sitting in her inbox, was

MSK is proud to join with National Cancer Institute (NCI)-designated cancer centers and other organizations to launch an awareness initiative urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.

… Thursday, May 20, 2021 MSK is proud to join with National Cancer Institute (NCI)-designated cancer centers and other organizations to launch an awareness initiative urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track. A joint statement

Patients with advanced kidney cancer can now take advantage of a new treatment option that has far fewer troubling side effects – this, according to a large, international trial led by Memorial Sloan Kettering Cancer Center investigators.

… Wednesday, August 21, 2013 Patients with advanced kidney cancer can now take advantage of a new treatment option that has far fewer troubling side effects – this, according to a large, international trial led by Memorial Sloan Kettering Cancer Center (MSKCC) investigators. Published in the August 22

Vaccinating children against the human papillomavirus can protect them from developing many types of cancer. Here’s what you need to know.

… Wednesday, January 27, 2016 Summary In January 2016, MSK joined other top cancer organizations in an unprecedented statement calling for increased vaccination against the human papillomavirus (HPV), which is known to cause many types of cancer. Here we provide updated information for parents on the HPV

Peter Scardino, MD, has been named the new Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center.

… Wednesday, July 5, 2006 Peter Scardino, MD, a urologic surgeon and internationally recognized authority on prostate cancer , has been named the new Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSKCC). Dr. Scardino, whose appointment became effective July 1, replaces

Learn how nurses at MSK also engage in cancer research projects designed to help improve patients’ treatment, symptoms, or experience.

… Tuesday, June 21, 2016 Summary Nurses are actively involved in improving patient care at MSK through cancer research projects. They’re also running clinical trials . Here, we interview three nurse researchers. Highlights Many nurses at MSK engage in cancer research as well as patient care. Molly Olm-Shipman

Biologists at Memorial Sloan Kettering Cancer Center have identified a set of genes expressed in human breast cancer cells that work together to remodel the network of blood vessels at the site of the primary tumor.

… Wednesday, April 11, 2007 Biologists at Memorial Sloan Kettering Cancer Center (MSKCC) have identified a set of genes expressed in human breast cancer cells that work together to remodel the network of blood vessels at the site of the primary tumor. These genes were also found to promote the spread of